Amedisys (AMED -6.5%) slides after beating on its Q4 EPS but coming up short on revenue. The...

|By:, SA News Editor

Amedisys (AMED -6.5%) slides after beating on its Q4 EPS but coming up short on revenue. The company also issued a dour outlook for FY13, now expecting an EPS of $0.60 - $0.70 on revenues of $1.425B - $1.45B. The Street view is for an EPS of $0.78 on revenues of $1.516B.